Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Development of a Topical Resveratrol Formulation for Commercial Applications Using Dendrimer Nanotechnology.

Pentek T, Newenhouse E, O'Brien B, Chauhan AS.

Molecules. 2017 Jan 14;22(1). pii: E137. doi: 10.3390/molecules22010137.

2.

Dendrimer nanotechnology for enhanced formulation and controlled delivery of resveratrol.

Chauhan AS.

Ann N Y Acad Sci. 2015 Aug;1348(1):134-40. doi: 10.1111/nyas.12816. Epub 2015 Jul 14.

PMID:
26173478
3.

Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide.

Singh MK, Pooja D, Kulhari H, Jain SK, Sistla R, Chauhan AS.

Eur J Pharm Sci. 2017 Jan 1;96:84-92. doi: 10.1016/j.ejps.2016.09.005. Epub 2016 Sep 8.

PMID:
27614111
4.

Pre-formulation studies of resveratrol.

Robinson K, Mock C, Liang D.

Drug Dev Ind Pharm. 2015;41(9):1464-9. doi: 10.3109/03639045.2014.958753. Epub 2015 Jul 21.

5.

Dendrimers for Drug Delivery.

Chauhan AS.

Molecules. 2018 Apr 18;23(4). pii: E938. doi: 10.3390/molecules23040938. Review.

6.

Improved oral delivery of resveratrol using proliposomal formulation: investigation of various factors contributing to prolonged absorption of unmetabolized resveratrol.

Basavaraj S, Betageri GV.

Expert Opin Drug Deliv. 2014 Apr;11(4):493-503. doi: 10.1517/17425247.2014.878701. Epub 2014 Jan 24.

PMID:
24456117
7.

Inclusion complexes of isoflavones with two commercially available dendrimers: Solubility, stability, structures, release behaviors, cytotoxicity, and anti-oxidant activities.

Zhao C, Wang Y, Su Y, Zhang H, Ding L, Yan X, Zhao D, Shao N, Ye X, Cheng Y.

Int J Pharm. 2011 Dec 15;421(2):301-9. doi: 10.1016/j.ijpharm.2011.09.044. Epub 2011 Oct 4.

PMID:
22001794
8.

Enhancement of in vivo human skin penetration of resveratrol by chitosan-coated lipid microparticles.

Scalia S, Trotta V, Iannuccelli V, Bianchi A.

Colloids Surf B Biointerfaces. 2015 Nov 1;135:42-9. doi: 10.1016/j.colsurfb.2015.07.043. Epub 2015 Jul 22.

PMID:
26241915
9.

Resveratrol nanoformulations: challenges and opportunities.

Summerlin N, Soo E, Thakur S, Qu Z, Jambhrunkar S, Popat A.

Int J Pharm. 2015 Feb 20;479(2):282-90. doi: 10.1016/j.ijpharm.2015.01.003. Epub 2015 Jan 5. Review.

PMID:
25572692
10.

Formulation of resveratrol entrapped niosomes for topical use.

Pando D, Matos M, Gutiérrez G, Pazos C.

Colloids Surf B Biointerfaces. 2015 Apr 1;128:398-404. doi: 10.1016/j.colsurfb.2015.02.037. Epub 2015 Feb 25.

PMID:
25766923
11.

Nanosized dendritic polyguanidilyated translocators for enhanced solubility, permeability, and delivery of gatifloxacin.

Durairaj C, Kadam RS, Chandler JW, Hutcherson SL, Kompella UB.

Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5804-16. doi: 10.1167/iovs.10-5388. Epub 2010 May 19.

PMID:
20484584
12.

Interaction between PAMAM-NH₂ G4 dendrimer and 5-fluorouracil in aqueous solution.

Buczkowski A, Sekowski S, Grala A, Palecz D, Milowska K, Urbaniak P, Gabryelak T, Piekarski H, Palecz B.

Int J Pharm. 2011 Apr 15;408(1-2):266-70. doi: 10.1016/j.ijpharm.2011.02.014. Epub 2011 Feb 16.

PMID:
21335079
13.

Dendrimers bind antioxidant polyphenols and cisplatin drug.

Abderrezak A, Bourassa P, Mandeville JS, Sedaghat-Herati R, Tajmir-Riahi HA.

PLoS One. 2012;7(3):e33102. doi: 10.1371/journal.pone.0033102. Epub 2012 Mar 13.

14.

Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: Comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations.

Chaudhary S, Gothwal A, Khan I, Srivastava S, Malik R, Gupta U.

Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:611-619. doi: 10.1016/j.msec.2016.11.122. Epub 2016 Dec 2.

PMID:
28024628
15.
16.

Effect of polyamidoamine dendrimer G3 and G4 on skin permeation of 8-methoxypsoralene--in vivo study.

Borowska K, Wołowiec S, Rubaj A, Głowniak K, Sieniawska E, Radej S.

Int J Pharm. 2012 Apr 15;426(1-2):280-283. doi: 10.1016/j.ijpharm.2012.01.041. Epub 2012 Jan 30.

PMID:
22310461
17.

Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol.

Balata GF, Essa EA, Shamardl HA, Zaidan SH, Abourehab MA.

Drug Des Devel Ther. 2016 Jan 5;10:117-28. doi: 10.2147/DDDT.S95905. eCollection 2016.

18.

Solubility and in vitro transdermal diffusion of riboflavin assisted by PAMAM dendrimers.

Filipowicz A, Wołowiec S.

Int J Pharm. 2011 Apr 15;408(1-2):152-6. doi: 10.1016/j.ijpharm.2011.01.033. Epub 2011 Jan 25.

PMID:
21272625
19.

Stability and solubility of trans-resveratrol are strongly influenced by pH and temperature.

Zupančič Š, Lavrič Z, Kristl J.

Eur J Pharm Biopharm. 2015 Jun;93:196-204. doi: 10.1016/j.ejpb.2015.04.002. Epub 2015 Apr 10.

PMID:
25864442
20.

Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications.

Gokce EH, Korkmaz E, Dellera E, Sandri G, Bonferoni MC, Ozer O.

Int J Nanomedicine. 2012;7:1841-50. doi: 10.2147/IJN.S29710. Epub 2012 Apr 11.

Supplemental Content

Support Center